RNS Number : 7754M
Silence Therapeutics PLC
11 May 2015
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Silence Therapeutics Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

Dilution due to additional placing of shares

X

3. Full name of person(s) subject to the
notification obligation:

Richard Griffiths and controlled undertakings

4. Full name of shareholder(s)
 (if different from 3.):


5. Date of the transaction and date on
which the threshold is crossed or
reached:

8 May 2015

6. Date on which issuer notified:

11 May 2015

7. Threshold(s) that is/are crossed or
reached:

24, 23, 22, 21%



 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

GB00B9GTXM62

13,017,176

13,017,176

14,409,248

14,409,248


20.64%




B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted

% of voting
rights

CFD



226,000

0.32%


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights xix,

 





 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

14,409,248

20.97%


 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

Cream Capital Limited

599,033

Blake Holdings Limited

6,697,071

Seren Capital Management Limited

5,657,974

Richard Griffiths direct holdings

566,180

Richard Griffiths indirect holdings

692,153

Oak Trust Limited

196,837


14,409,248



CFD

226,000

Total

14,635,248

 

The above undertakings are all controlled by Richard Griffiths

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

James Sutcliffe

15. Contact telephone number:

01534 719 761

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAURRVKAVAAR